Selective amyloid-β lowering agents

BMC Neuroscience

Volumn 9, Issue SUPPL. 2, 2008, Pages

  Wolfe, Michael S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; BETA SECRETASE; BETA SECRETASE INHIBITOR; COMPOUND 1367; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; HERMES ANTIGEN; IBUPROFEN; IMATINIB; INDOMETACIN; JANUS KINASE 3; LDDN 9918; LOW DENSITY LIPOPROTEIN RECEPTOR; NECTIN 1; NERVE CELL ADHESION MOLECULE; NEU DIFFERENTIATION FACTOR; NICASTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; PRESENILIN; SULINDAC SULFIDE; TARENFLURBIL; UNCLASSIFIED DRUG; UVOMORULIN; PROTEINASE INHIBITOR; SECRETASE;

ALZHEIMER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; HUMANS; MOLECULAR STRUCTURE; PROTEASE INHIBITORS;

EID: 57449095998     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-S2-S4     Document Type: Conference Paper

References (19)

1. Beher D Graham SL Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease Expert Opin Investig Drugs 2005, 14:1385-1409 10.1517/13543784.14.11.1385 16255678
2. Howlett DR Simmons DL Dingwall C Christie G In search of an enzyme: The beta-secretase of Alzheimer's disease is an aspartic proteinase Trends Neurosci 2000, 23:565-570 10.1016/S0166-2236(00)01647-7 11074266
3. Cai H Wang Y McCarthy D Wen H Borchelt DR Price DL Wong PC BACE1 is the major beta-secretase for generation of Abeta peptides by neurons Nat Neurosci 2001, 4:233-234 10.1038/85064 11224536
4. Luo Y Bolon B Kahn S Bennett BD Babu-Khan S Denis P Fan W Kha H Zhang J Gong Y et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation Nat Neurosci 2001, 4:231-232 10.1038/85059 11224535
5. Willem M Garratt AN Novak B Citron M Kaufmann S Rittger A DeStrooper B Saftig P Birchmeier C Haass C Control of peripheral nerve myelination by the beta-secretase BACE1 Science 2006, 314:664-666 10.1126/ science.1132341 16990514
6. Hong L Koelsch G Lin X Wu S Terzyan S Ghosh AK Zhang XC Tang J Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor Science 2000, 290:150-153 10.1126/science.290.5489.150 11021803
7. Ghosh AK Bilcer G Hong L Koelsch G Tang J Memapsin 2 (beta-secretase) inhibitor drug, between fantasy and reality Curr Alzheimer Res 2007, 4:418-422 10.2174/156720507781788864 17908045
8. Wolfe MS The gamma-secretase complex: Membrane-embedded proteolytic ensemble Biochemistry 2006, 45:7931-7939 10.1021/bi060799c 16800619
9. Kopan R Ilagan MX Gamma-secretase: Proteasome of the membrane? Nat Rev Mol Cell Biol 2004, 5:499-504 10.1038/nrm1406 15173829
10. Searfoss GH Jordan WH Calligaro DO Galbreath EJ Schirtzinger LM Berridge BR Gao H Higgins MA May PC Ryan TP Adipsin: A biomarker of gastrointestinal toxicity mediated by a functional gamma secretase inhibitor J Biol Chem 2003, 29:29
11. Wong GT Manfra D Poulet FM Zhang Q Josien H Bara T Engstrom L Pinzon-Ortiz M Fine JS Lee HJ et al. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation J Biol Chem 2004, 279:12876-12882 10.1074/jbc.M311652200 14709552
12. Weggen S Eriksen JL Das P Sagi SA Wang R Pietrzik CU Findlay KA Smith TE Murphy MP Bulter T et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity Nature 2001, 414:212-216 10.1038/35102591 11700559
13. Weggen S Eriksen JL Sagi SA Pietrzik CU Ozols V Fauq A Golde TE Koo EH Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity J Biol Chem 2003, 278:31831-31837 10.1074/jbc.M303592200 12805356
14. Zhou Y Su Y Li B Liu F Ryder JW Wu X Gonzalez-DeWhitt PA Gelfanova V Hale JE May PC et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho Science 2003, 302:1215-1217 10.1126/science.1090154 14615541
15. Sato T Nyborg AC Iwata N Diehl TS Saido TC Golde TE Wolfe MS Signal peptide peptidase: Biochemical properties and modulation by nonsteroidal antiinflammatory drugs Biochemistry 2006, 45:8649-8656 10.1021/bi060597g 16834339
16. Kukar TL Ladd TB Bann MA Fraering PC Narlawar R Maharvi GM Healy B Chapman R Welzel AT Price RW et al. Substrate-targeting gamma-secretase modulators Nature 2008, 453:925-929 10.1038/nature07055 18548070
17. Netzer WJ Dou F Cai D Veach D Jean S Li Y Bornmann WG Clarkson B Xu H Greengard P Gleevec inhibits beta-amyloid production but not Notch cleavage Proc Natl Acad Sci USA 2003, 100:12444-12449 218777 14523244 10.1073/pnas.1534745100
18. Fraering PC Ye W LaVoie MJ Ostaszewski BL Selkoe DJ Wolfe MS γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide binding site J Biol Chem 2005, 280:41987-41996 1523323 16236717 10.1074/jbc.M501368200
19. Bakshi P Liao YF Gao J Ni J Stein R Yeh LA Wolfe MS A high-throughput screen to identify inhibitors of amyloid beta-protein precursor processing J Biomol Screen 2005, 10:1-12 10.1177/1087057104270068 15695338